How to legally get Strattera online in Illinois

What You Need to Know About Getting Non-Stimulant ADHD Medication via Telehealth

If you’re exploring ADHD treatment options that don’t involve stimulants, you may be wondering if medications like Strattera (atomoxetine) can be prescribed through telehealth services. The short answer is yes—and the process is typically more straightforward than for stimulant medications. This comprehensive guide breaks down everything you need to know about getting non-stimulant ADHD medication via telehealth in 2025.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Understanding Strattera: A Non-Controlled ADHD Medication

Unlike stimulant medications such as Adderall or Ritalin, Strattera (atomoxetine) is not a controlled substance. This key distinction significantly impacts how it can be prescribed via telehealth.

Strattera works differently than stimulants—it’s a selective norepinephrine reuptake inhibitor that increases norepinephrine levels in the brain to help improve attention and decrease impulsivity. Because it’s not controlled by the DEA, Strattera:

• Can be prescribed with refills (up to 5-11 months depending on state)
• Doesn’t require monthly prescriptions
• Isn’t subject to the strict telehealth limitations that apply to controlled substances
• Is generally easier to obtain through telehealth platforms

This makes Strattera an appealing option for patients who want the convenience of telehealth treatment without navigating the complex regulations surrounding stimulant medications.

Federal Rules for Telehealth Prescribing of Non-Stimulants

When it comes to non-stimulant ADHD medications like Strattera, federal law imposes no special restrictions on telehealth prescribing. This is because the Ryan Haight Act, which governs online prescribing of medications, only restricts controlled substances.

Key points about federal regulations:

• No in-person exam requirement: Unlike with stimulants (which currently have temporary COVID-era waivers through December 31, 2025), there’s no federal requirement for an in-person examination before prescribing Strattera via telehealth.
• Standard of care applies: Providers must still conduct a proper evaluation, make an appropriate diagnosis, and ensure the medication is clinically indicated—just as they would in person.
• DEA registration: While prescribers need a DEA registration to prescribe controlled substances, this specific requirement doesn’t apply to Strattera (though prescribers still need appropriate medical licensing).

This means that from a federal perspective, getting Strattera through telehealth is straightforward and permanent—not dependent on temporary pandemic waivers that apply to stimulant medications.

State-by-State Telehealth Rules for Non-Stimulant ADHD Medications

While federal law doesn’t restrict telehealth prescribing of non-stimulants like Strattera, state laws can add their own requirements. Fortunately, most states have embraced telehealth for non-controlled medications. Here’s how key states handle it:

California

• Telehealth prescribing: Fully permitted for non-stimulants
• In-person requirement: None for Strattera
• Recent developments: AB 1503 (proposed in 2025) aims to further modernize telehealth prescribing definitions

New York

• Telehealth prescribing: Allowed for non-stimulants
• In-person requirement: None for Strattera (though NY reinstated in-person requirements for controlled substances in 2025)
• Recent developments: Despite tightening rules for controlled substances, NY remains telehealth-friendly for non-controlled medications

Florida

• Telehealth prescribing: Permitted for non-stimulants
• In-person requirement: None for Strattera
• Recent developments: Florida’s telehealth rules were made permanent through legislation in 2022, providing stable access to telehealth services

Texas

• Telehealth prescribing: Allowed for non-stimulants
• In-person requirement: None for Strattera
• Special considerations: Texas is generally telehealth-friendly, especially for behavioral health conditions

Alabama

• Telehealth prescribing: Allowed, but with more restrictions
• In-person requirement: Periodic (annual) in-person exams are required for ongoing telehealth treatment, though mental health services (including ADHD) may be exempt
• Special considerations: Alabama has stricter telehealth policies overall, but non-stimulants still face fewer barriers than controlled medications

New Hampshire

• Telehealth prescribing: Fully allowed for non-stimulants
• In-person requirement: None for Strattera
• Recent developments: SB 252 (effective August 2025) removed prior in-person requirements, greatly expanding telehealth flexibility

The pattern is clear: across states, non-stimulant ADHD medications like Strattera can be prescribed via telehealth without the strict in-person visit requirements that might apply to stimulants. This makes them an accessible option for patients who prefer the convenience of telehealth care.

Who Can Prescribe Strattera via Telehealth?

The authority to prescribe Strattera via telehealth varies by practitioner type and state:

Physicians (MD/DO)

• Can prescribe Strattera via telehealth in all 50 states
• Must be licensed in the patient’s state
• Must follow standard of care for ADHD diagnosis and treatment

Nurse Practitioners (NPs)

• Can prescribe Strattera in all states (either independently or collaboratively)
• States with independent practice authority for NPs (like California, New York, New Hampshire, and Illinois) allow NPs to prescribe without physician oversight
• States with collaborative requirements (like Florida, Texas, Alabama, and Georgia) require NPs to have a physician agreement, but they can still prescribe non-controlled medications like Strattera

Physician Assistants (PAs)

• Can prescribe Strattera in all states under their scope of practice
• All states require some form of physician collaboration for PAs
• The collaboration requirements vary by state but are typically less restrictive for non-controlled medications

At Klarity Health, we carefully match patients with licensed providers in their state who have the appropriate prescribing authority, ensuring full compliance with all relevant regulations while providing convenient access to care.

The Telehealth ADHD Evaluation Process

When seeking Strattera or other non-stimulant ADHD medications via telehealth, you can expect a thorough evaluation process that mirrors in-person care:

1. Initial assessment: A comprehensive video evaluation with a licensed provider who will:

• Review your medical and psychiatric history
• Discuss your ADHD symptoms and how they impact your daily functioning
• Apply DSM-5 diagnostic criteria to assess for ADHD
• Consider other possible conditions that might explain your symptoms

1. Diagnostic decision: Based on the assessment, the provider will determine if ADHD is the appropriate diagnosis and if medication is indicated.

2. Treatment planning: If ADHD is diagnosed, the provider will discuss treatment options, including:

• Benefits and potential side effects of Strattera
• Expected timeline for improvement (Strattera typically takes 4-6 weeks to reach full effectiveness)
• Lifestyle modifications and non-medication strategies
• Other treatment considerations specific to your situation

1. Prescription process: If Strattera is prescribed:

• The prescription is typically sent electronically to your preferred pharmacy
• You can usually get a 30-90 day supply, with refills as appropriate
• Your provider will explain dosing instructions and what to expect

1. Follow-up care: Regular follow-up appointments to monitor:

• Medication effectiveness
• Side effects management
• Dosage adjustments as needed
• Overall treatment progress

The evaluation process is designed to be thorough while offering the convenience of receiving care from home. Most telehealth providers use secure, HIPAA-compliant platforms that make the experience straightforward and private.

Patient Eligibility for Telehealth ADHD Treatment

While telehealth makes ADHD treatment more accessible, not everyone is an ideal candidate. Here’s who typically qualifies for telehealth ADHD treatment with non-stimulants:

Good candidates include:

• Adults with suspected or previously diagnosed ADHD
• Patients without severe psychiatric comorbidities that require in-person management
• Those who can reliably attend video appointments
• Patients seeking non-stimulant options like Strattera
• Those with stable vital signs and no severe cardiovascular issues

Patients who might need in-person care:

• Children under 18 (policies vary by telehealth provider)

– Those with complex medical conditions that require physical examination

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment